LAZR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Luminar Technologies, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Luminar Technologies, Inc. ("Luminar" or "the Company") (NASDAQ:LAZR) and certain of its officers. Class Definition This lawsuit seeks to recover […]

RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

TEM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Tempus AI, Inc. to Contact the Firm Today!

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ:TEM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

RCKT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Rocket Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. ("Rocket" or "the Company") (NASDAQ:RCKT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of PepGen Inc. to Contact the Firm Today!

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

DDD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of 3D Systems Corporation to Contact the Firm Today!

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against 3D Systems Corporation ("3D Systems" or "the Company") (NYSE:DDD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Hopewell Fund Announces Anna Brower as Inaugural President

Washington, DC, Aug. 06, 2025 (GLOBE NEWSWIRE) — Hopewell Fund is pleased to announce Anna Brower as its inaugural president. Brower is a highly accomplished public service professional, bringing a wealth of management, operations, strategy, and communications expertise to Hopewell Fund. Brower will begin in the role in September. A 501(c)(3) public charity, Hopewell Fund

Purple Biotech Reports Second Quarter 2025 Financial Results

(NASDAQ:PPBT),(TASE:PPBT.TA), Platform validating preclinical data presented at EACR 2025 for CAPTN-3 tri-specific T cell engager show synergistic activity of the platform's masked CD3, NKG2A, and tumor-associated antigen arms First CAPTN-3 trispecific antibody targeting novel tumor associated antigen, 5T4, advances toward first-in-human clinical trials, with IND submission expected in 2026 Positive Phase 2 data from CM24

Mingteng International’s Subsidiary Entered into Strategic Cooperation Framework Agreement with Suzhou Lvkon Transmission Technology to Strengthen Partnership and Enhance Competitiveness in the New Energy Commercial Vehicle Market

(NASDAQ:MTEN), Wuxi, China, Aug. 06, 2025 (GLOBE NEWSWIRE) — Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in China, today announced that its subsidiary, Wuxi Mingteng Mould Technology Co., Ltd., or Wuxi Mingteng, entered into a strategic cooperation framework agreement (the “Agreement”) with Suzhou Lvkon Transmission

Royalty Pharma Reports Second Quarter 2025 Results

(NASDAQ:RPRX), Portfolio Receipts growth of 20% to $727 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $364 million Raised full year 2025 guidance: Portfolio Receipts expected to be $3,050 to $3,150 million NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for

Scroll to Top